Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gilead Sciences, Inc. (GILD) vs Tractor Supply Co (TSCO) Price & Performance

Gilead Sciences, Inc.Trade
Tractor Supply CoTrade

Price performance (Past 24H)

Key statistics

Gilead Sciences, Inc. vs Tractor Supply Co — how do they compare? Gilead Sciences, Inc. trades at $133.21 (market cap $163.51B), while Tractor Supply Co trades at $31.15 (market cap $15.82B). The key difference: Gilead Sciences, Inc. is far larger — about 10.3× Tractor Supply Co's market cap, and Tractor Supply Co pays the higher dividend (3.18%). Which is the better fit depends on your goals.

GILDTSCO
Market Cap
$163.51B$15.82B
Sector
HealthConsumer Cyclical
52-Week High
$155.80$62.65
52-Week Low
$108.22$29.14
Enterprise Value
$178.05B$22.01B
Dividend Yield
2.49%3.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gilead Sciences, Inc.

Gilead Sciences (GILD) trades at $130.04, down 1.04% on the day, with technical indicators showing a bearish bias while fundamentals remain strong. The company has beaten earnings expectations for three consecutive quarters, maintains robust profitability with a 30.99% net income margin, and recently secured FDA and European Commission approvals for expanded use of its oncology drug Trodelvy. Analyst consensus remains overwhelmingly positive with a $152.83 price target representing 17.5% upside potential.

The outlook for GILD is favorable with strong earnings momentum, expanding oncology portfolio, and solid cash generation, though risks include patent expirations, competitive pressures in HIV treatments, and recent negative cash flow trends. The stock presents a compelling opportunity for investors seeking exposure to a profitable biopharmaceutical company with growth catalysts, supported by Wall Street's bullish sentiment and recent regulatory wins.

Tractor Supply Co

Tractor Supply (TSCO) trades at $30.55, up 1.03% on the day, with a bearish technical signal from moving averages. Recent earnings missed expectations in Q4 2025 and Q1 2026, though Q2 2026 results are pending. Revenue grew to $15.52B in 2025, with a net income margin of 6.91% and a P/E ratio of 14.86. The company announced a partnership with Instacart for delivery services and maintains a dividend, with the next payment scheduled for June 2026.

The outlook is mixed: analyst consensus is a 'Buy' with a $39.14 price target, implying significant upside, but near-term headwinds include consumer pressure and recent earnings misses. Risks involve competitive retail dynamics and macroeconomic sensitivity. The stock's current valuation presents a potential opportunity if execution improves, but volatility may persist until earnings momentum recovers.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Read more on GILD

About Tractor Supply Co

Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).

Read more on TSCO